(02) 9926 4726
SydneyVital.admin@sydney.edu.au

News and Event

Flagship 2 collaboration paper wins 2nd prize in the International-Atom Indonesia Best Paper Awards

A team of international collaborators under Sydney Vital’s Flagship 2, has won the 2nd prize in the 2nd International-Atom Indonesia Best Paper Awards 2018 (I-AIBPA 2018)

Read more

Grace Lim Awarded Sydney Vital Travel Award

Ms Grace Lim, the PhD student under our Thyroid Cancer TCE (Translational Centre of Excellence), was awarded a Sydney Vital Travel Grant to attend and present her research study at this year’s annual meeting of the American Thyroid Association.

Read more

A report on Outcomes 2014-2018

On 5th November,  Prof Alexander Engel ( committee member and director of Sydney Vital) gave a presentation of Sydney Vital at the Surgical Grand Rounds.

After introducing our current position and roles, Prof Engel summarised our achievements and outcomes over the past four years comprehensively and addressed Vital’s plan and vision for the upcoming years.

For access to the full presentation content, please click here.

 

Read more

Dr Sarah Hayes Awarded Sydney Vital Travel Award

Dr Sarah Hayes, one of our early career researchers who specializes in proteomics research, was awarded a Sydney Vital Travel Grant to attend the 17th Human Proteome Organisation (HUPO) World Congress (Sept 30 – Oct 3, 2018)

Read more

2018 Neuroendocrine Tumour Q&A Session

On the August 9, 2018, Sydney Vital teamed up with The Unicorn Foundation to host the 2018 Neuroendocrine Tumour Q&A Session. The session saw over 100 attendees come together to hear about what’s new in Neuroendocrine Tumours and why research plays a vital role in patient outcomes.
Read more

Sydney Vital Seed Funding – Closed

Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $25,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought. The ideas to be tested should be (i) new in concept and (ii) distinct from currently or previously funded research. Projects should focus on Translational Cancer Research and closely align with one or more of Sydney Vital’s Flagship Programs and/or Translational Cancer Research Centres (TCE) which are;

Flagships

Inflammation
Translational Theranostics
Nanotechnology

TCEs

Pancreatic Cancer
Thyroid Cancer
Breast Cancer Implementation
Neuroendocrine Tumours
Glioblastoma
Sydney 1000 CRC
Adrenocortical Cancer

 

Key Dates

Call for Applications: 14 February 2018

Closing Date for Applications: 9th March 2018

 

Useful Documents:

Sydney Vital_Seed Funding Award_Guidelines_Feb 2018

SV_Seed Funding_Application Form_Feb 2018

Any queries should be directed to sydneyvital.admin@sydney.edu.au

Read more

Scalp Cooling – What Is It?

Chemotherapy induced hair-loss can be very demotivating, distressing and it knocks the confidence of many who have to go through it.

Read more

What is Translational Cancer Research?

Cancer research is one of the most talked about topics and rightly so. Cancer research is making incredible breakthroughs and paving the way for a future where cancer can be cured and prevented.

Read more

Research Scholarship Applications Round 5 – CLOSED

Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.

Read more

Funding Awarded By Sydney Vital

The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.

#AwardeeInstitutionSupervisorResearch TitleAmount
Awarded
1Jerikho BulanadiKolling Institute of Medical ResearchProf Ross SmithChemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.$15,000
2Emma ColvillSydney University Medical SchoolProf Paul KeallThe bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer$15,000
3Grace GiffordHaematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, SydneyDr William StevensonGene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.$15,000
4Dr Anthony GloverKolling Institute of Medical Research, Royal North Shore HospitalProf Stanley SidhuNoncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.$15,000
5Diana HatoumFaculty of Science, UTS SydneyDr Najah NassifA Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.$15,000
6Samuel BrennanFaculty of Science, UTS SydneyDr Rose Martiniello-WilksDevelopment of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.$15,000
7Ben HarrisSydney Medical School, University of SydneyDr Kellie CharlesInvestigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.
$15,000
8Adrian LeeBill Walsh Translation Cancer Research Laboratory, Kolling InstituteDr Viive Howell"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with
glioblastoma multiforme?"
$15,000
9Jaynish ShahSydney Medical School, University of SydneyProf Deborah MarshInvestigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?$15,000
Read more